Jane Street
KPRX icon

Jane Street’s Kiora Pharmaceuticals KPRX Stock Holding History

Jane Street’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-87
Closed -$47K – 10688
2021
Q4 		$47K Sell
87
-10
-10% -$5.64K ﹤0.01% 9554
2021
Q3 		$78K Buy
+97
New +$82.4K ﹤0.01% 9394
2018
Q4 		– Sell
-3
Closed -$5K – 5359
2018
Q3 		$5K Buy
+3
New +$8.06K ﹤0.01% 5002

Other funds holding KPRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Jane Street's KPRX Position: Q1 2022 in Review

Jane Street sold out of Kiora Pharmaceuticals (KPRX) in Q1 2022, closing a stake of 87 shares — an estimated $47K sold.

Jane Street first reported a position in KPRX in Q3 2018 and held it in 3 quarters. The position peaked at $78K in Q3 2021. 15 funds tracked by Wall St. Rank hold KPRX as of Q1 2022.

  • Jane Street reported no remaining Kiora Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 87 Kiora Pharmaceuticals shares in Q1 2022, an estimated $47K.
  • Jane Street first reported a position in Kiora Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Jane Street's Kiora Pharmaceuticals position peaked at $78K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.